АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

Скрининг по кардиотоксическим эффектам

Список использованной литературы

1. А.Г. Румянцев, Е.В. Самочатова «Практическое руководство по детским болезням. Гематология/онкология детского возраста». Медпрактика-М, Москва 2004.

2. Е.В. Самочатова «Болезнь Ходжкина у детей». Алтус, Москва 1997.

3. Ю.А.Криволапов, Е.Е.Леенман «Морфологическая диагностика лимфом». КОСТА, Санкт-Петербург,2006

4. Nancy Lee Harris «Hodgkin’s Lymphomas: classification, diagnosis, and grading» Seminars in Hematology, Vol 36, No 3, 1999

5. G.Schellong, D.Koerholz, K.Dieckmann, R.Poetter «Treatment recommendations for Children and Adolescents with Hodgkin’s Lymphoma in Russia», 2007

6. Engert A, Eichenauer DA, Dreyling M.; ESMO guidelines working group. Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:168-71

7. Hematology: Basic Principles and Practice, Sixth Edition

Ronald Hoffman, Edward J. Benz, Leslie E. Silberstein, Helen E. Heslop, Jeffrey I. Weitz, and John AnastasiChapter 74, 1138-1156Copyright © 2013, Elsevier Inc.

8. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, Eich HT, Mueller-Hermelink HK, Kanz L, Greil R, Rank A, Paulus U, Smardova L, Huber C, Dörken B, Nerl C, Krause SW, Mueller RP, Fuchs M, Engert A - J. Clin. Oncol. - Nov 2011; 29(32); 4234-42

9. Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).

Sieniawski M, Reineke T, Nogova L, Josting A, Pfistner B, Diehl V, Engert A - Blood - Jan 2008; 111(1); 71-6

10. The discovery and development of brentuximabvedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Senter PD, Sievers EL - Nat. Biotechnol. - Jul 2012; 30(7); 631-7

11. Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.

Eichenauer DA, Fuchs M, Pluetschow A, Klimm B, Halbsguth T, Böll B, von Tresckow B, Nogová L, Borchmann P, Engert A - Blood - Oct 2011; 118(16); 4363-5

12. Involved-field radiotherapy for advanced Hodgkin's lymphoma.

Aleman BM, Raemaekers JM, Tirelli U, Bortolus R, van 't Veer MB, Lybeert ML, Keuning JJ, Carde P, Girinsky T, van der Maazen RW, Tomsic R, Vovk M, van Hoof A, Demeestere G, Lugtenburg PJ, Thomas J, Schroyens W, De Boeck K, Baars JW, Kluin-Nelemans JC, Carrie C, Aoudjhane M, Bron D, Eghbali H, Smit WG, Meerwaldt JH, Hagenbeek A, Pinna A, Henry-Amar M, - N. Engl. J. Med. - Jun 2003; 348(24); 2396-406

13. Brentuximabvedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.

Rothe A, Sasse S, Goergen H, Eichenauer DA, Lohri A, Jäger U, Bangard C, Böll B, von BergweltBaildon M, Theurich S, Borchmann P, Engert A - Blood - Aug 2012; 120(7); 1470-2

14. Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

Schulz H, Rehwald U, Morschhauser F, Elter T, Driessen C, Rüdiger T, Borchmann P, Schnell R, Diehl V, Engert A, Reiser M - Blood - Jan 2008; 111(1); 109-11

Дата добавления: 2015-09-18 | Просмотры: 347 | Нарушение авторских прав